COSTIM logo — Real estate, three steps ahead

COSTIM

Real estate, three steps ahead

Founded 2019 Italy Italy 81 employees Series A Total: $22.00M Biotechnology

General Information

Company Name COSTIM
Founded Year 2019
Location Italy Italy
Employees 81
Industries Biotechnology
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with COSTIM. To contact COSTIM, visit costim.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does COSTIM compare?

A PDF of COSTIM and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting COSTIM soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About COSTIM

COSTIM is a Real Estate developer with an industrial profile, focusing on nationwide operations. The company's mission is to execute major "turnkey" urban regeneration projects based on the ChorusLife concept, with a prototype currently being completed in Bergamo and two new projects in the planning stages. The group's industrial expertise is derived from leading market operators, Impresa Percassi, Gualini, and Elmet, with a focus on digitization and innovation. Utilizing its proprietary digital platform, COSTIM offers cutting-edge solutions for urban transformation, with a strong focus on sustainability and digital real estate servitization. The company positions itself as a reliable partner throughout the entire design and implementation process, with the CEO and General Director being Davide Albertini Petroni, and the Chairman Massimo Tivegna. The recent $22.00M Series A investment from Atlas Venture, MPM Capital, Partners Innovation Fund, and Johnson & Johnson Development Corporation signifies a strong investment interest in the company's endeavors. The company was founded in 2019 and is headquartered in Italy. #justonegroup

Business keywords: Real Estate Development, Urban Regeneration, Construction Envelopes, Digital Real Estate Servitization, Smart Human District, Antibody Agents, Cancer Treatment, General Contracting, Energy Services, Facility Management, Urban Transformation, Sustainability Criteria, Investment Management, Digital Platforms

Services & Products

End-to-end Urban Regeneration Projects
Sustainable Real Estate Solutions
Digital Servitization in Real Estate

Target Customers

Real Estate Investors Stakeholders Urban Communities

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $22.00M 4
Atlas Venture, MPM Capital +2
01 Mar 2013
Seed Round Undisclosed 1
MPM Capital
01 Jan 2012

COSTIM Alternatives & Competitors

View All Alternatives
COSTIM vs
Novartis
Novartis Switzerland

Reimagining medicine by transforming cancer

IPO
86998 employees
Biotechnology, Pharmaceutical
COSTIM vs
Amgen
Amgen United States

#WeareBiotech

IPO
40947 employees
Biotechnology, Health Care
COSTIM vs
Freenome
Freenome United States

Outpacing cancer starts with early detection

403 employees
Biotechnology, Pharmaceutical

FAQ About COSTIM

Real estate, three steps ahead
COSTIM was founded in 2019.
COSTIM is headquartered in Italy.
COSTIM operates in Biotechnology. Its work centres on Real Estate Development, Urban Regeneration, Construction Envelopes and Digital Real Estate Servitization. Its customers include Real Estate Investors, Stakeholders and Urban Communities.
COSTIM has approximately 81 employees.
COSTIM has completed 2 funding rounds, raising a total of $22.00M. The latest funding stage is Series A.
COSTIM offers: End-to-end Urban Regeneration Projects, Sustainable Real Estate Solutions, Digital Servitization in Real Estate.
Top alternatives and competitors to COSTIM include Novartis, Amgen, Freenome, Gan & Lee Pharmaceuticals, MacroGenics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
COSTIM and Novartis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for COSTIM, https://bouncewatch.com/company/costim, updated 25 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes